Inventor · disambiguated record
Edwin Bremer
Also filed as: BREMER EDWIN
6 granted patents·7 pending applications·8 citations·filing 2008–2025
74Inventor score
Top patents by PatentIndex Score
13 records- 0191US11130796B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Sep 28, 2021·6 cites·11 claims
- 0284US12331098B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Granted Jun 17, 2025·0 cites·20 claims
- 0382US11702458B2PD1-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Jul 18, 2023·2 cites·24 claims
- 0478US2025304653A1SIRPalpha-41BBL FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2025·Application pending·0 cites
- 0574US11897937B2SIRPalpha-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2021·Granted Feb 13, 2024·0 cites·11 claims
- 0671US2024010700A1Pd1-41bbl fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Application pending·0 cites
- 0769US2023220040A1Pd1-cd70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Application pending·0 cites
- 0864US2022204586A1SIRP alpha-CD70 FUSION PROTEIN AND METHODS OF USE THEREOFKAHR MEDICAL LTD·Filed 2022·Application pending·0 cites
- 0959US11566060B2PD1-CD70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Jan 31, 2023·0 cites·7 claims
- 1059US11299530B2SIRP alpha-CD70 fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Apr 12, 2022·0 cites·7 claims
- 1152US2024076346A1Type i membrane proteins heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2021·Application pending·0 cites
- 1250US2022267409A1Heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2020·Application pending·0 cites
- 1342US2008234177A1Targeting-enhanced activation of galectinsBREMER EDWIN·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →